Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05260177
NA

Study on the Effect of 40 Hz Non-Invasive Light Therapy System

Sponsor: Zealand University Hospital

View on ClinicalTrials.gov

Summary

The ALZLIGHT STAGE III Study is a continuation of the ALZLIGHT Pilot - Study on Safety, Feasibility and Neural Activation of Non-Invasive Light Therapy System. As with the first two stages, this study will examine whether entrainment of 40 Hz neural oscillation by novel 40 Hz Invisible Spectral Flicker is a potential therapy for Alzheimer's Disease. In order to examine this, 62 patients with mild to moderate Alzheimer's Disease will be recruited. The patients will be exposed to the Non-Invasive Light Therapy System for 1 hour a day for 6 months. The effect will be measured by a combination of electroencephalography, cognitive testing, functional magnetic resonance imaging, magnetic resonance spectroscopy and actigraphy.

Official title: ALZLIGHT Stage III - Study on the Effect of 40 Hz Non-Invasive Light Therapy System

Key Details

Gender

All

Age Range

55 Years - Any

Study Type

INTERVENTIONAL

Enrollment

62

Start Date

2022-09-20

Completion Date

2026-12-01

Last Updated

2024-01-24

Healthy Volunteers

No

Interventions

DEVICE

Light Therapy System (LTS): Active Setting

Exposure for 1 hour á day for consecutive days

DEVICE

Light Therapy System (LTS): Sham Setting

Exposure for 1 hour á day for consecutive days

Locations (1)

Zealand University Hospital

Roskilde, Denmark